Business

AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its full-year and fourth-quarter 2025 financial results on Wednesday, February 4, 2026, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

articleAbbvie Inc.January 7, 20261/company/abbvie-inc/news/abbvie-to-host-full-year-and-fourth-quarter-2025-earnings-conference-call
AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call

About this update from Abbvie Inc.

[{"type":"text","content":"NORTH CHICAGO, Ill., Jan. 7, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its full-year and fourth-quarter 2025 financial results on Wednesday, February 4, 2026, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.","length":448,"tagName":"p"},{"type":"text","content":"About AbbVie","length":12,"tagName":"p"},{"type":"text","content":"AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.","length":542,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;","val":[{"type":"text","content":"Media:","length":6,"tagName":"p","attribs":{}},{"type":"text","content":"Gabby Tarbert (224) [email protected]","length":58,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;","val":[{"type":"text","content":"Investors:","length":10,"tagName":"p","attribs":{}},{"type":"text","content":"Liz Shea (847) [email protected]","length":44,"tagName":"p","attribs":{}}]}]}],"length":119},{"type":"text","content":" ","length":6,"tagName":"p"},{"type":"image","alt":"Cision","displaySize":"","headline":null,"caption":"Cision","className":"","disableSlideshowImg":false,"size":{"original":{"width":16,"height":16,"url":"https://media.zenfs.com/en/prnewswire.com/dfc09b8ad6e963df1fc648eedb2e5816"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/IrVKUkbXUdSJyBErvjL2dw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2O2g9MzY7Y2Y9d2VicA--/https://media.zenfs.com/en/prnewswire.com/dfc09b8ad6e963df1fc648eedb2e5816","width":16,"height":16}}},{"type":"t...

More updates from Abbvie Inc.

AbbVieInvestor Relations websitePRNewswire